Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
July 10, 2026 by weareinnovation.global
The TPD Revision and Europe’s Innovation Economy: A Review of the Evidence [Briefing Paper]
Europe’s review of the Tobacco Products Directive is not only a health policy question — it is also a test of whether regulation can keep pace with innovation. If lower-risk nicotine products are treated through the same restrictive lens as cigarettes, consumers may lose access to better alternatives while responsible businesses face unnecessary barriers. Evidence should guide the revision, not fear of new technology. A smarter framework would protect young people, support adult smokers who want to switch and allow innovation to reduce harm.
July 09, 2026 by quitlikesweden.org
For The First Time FDA Authorises Modified Risk Claims for Nicotine Pouches: A Milestone for International Public Health
For the first time, the FDA has authorised modified risk claims for nicotine pouches — a milestone that goes beyond one product category. It signals that regulators can recognise a basic public health principle: smoke-free products should not be treated as if they carry the same risks as cigarettes. Clear, evidence-based communication can help adult smokers understand where risk actually lies and make better decisions. International tobacco policy should learn from this shift and regulate nicotine according to harm, not habit.
July 06, 2026 by regulatorwatch.com
Untethered | FDA’s Flavor Policy Defies Reality | RegWatch
The FDA’s flavour policy increasingly appears disconnected from how adult smokers actually switch away from cigarettes. Flavours are not just a youth issue — for many adults, they help make vaping a workable alternative to combustible tobacco. If regulation removes the products people find acceptable, it may weaken harm reduction while leaving cigarettes widely available. Public health policy should reflect real-world behaviour, not assumptions that ignore why switching succeeds.
July 06, 2026 by regulatorwatch.com
Untethered | FDA’s Flavor Policy Defies Reality | RegWatch
The FDA’s flavour policy increasingly appears disconnected from how adult smokers actually switch away from cigarettes. Flavours are not just a youth issue — for many adults, they help make vaping a workable alternative to combustible tobacco. If regulation removes the products people find acceptable, it may weaken harm reduction while leaving cigarettes widely available. Public health policy should reflect real-world behaviour, not assumptions that ignore why switching succeeds.
July 03, 2026 by clearingtheair.eu
Nearly half of online pouch customers tried them to quit smoking or vaping, survey finds
Survey findings suggest that many online nicotine pouch customers are using them as part of a move away from smoking or vaping. Nearly half reportedly tried pouches to quit, showing that smoke-free alternatives can play a role in real-world behaviour change. Policy should recognise why adults choose these products rather than assuming all use is the same. Harm reduction works best when regulation reflects consumer motivations, relative risk and practical routes away from more harmful products.
July 03, 2026 by gfn.tv
THR Unfiltered #2 | How should we think about nicotine addiction?
Nicotine addiction should be understood with nuance, not moral panic. Dependence is real, but it should not be confused with the harms caused by burning tobacco. For people who smoke, moving to lower-risk nicotine products can reduce exposure to the toxicants responsible for most smoking-related disease. Better policy starts by separating addiction, risk and harm — and by helping people make safer choices.
July 03, 2026 by dailycaller.com
What The FDA’s Latest Ruling Could Mean For Future Of Nicotine Pouches
The FDA’s ruling on nicotine pouches is a major step towards honest relative-risk communication. By recognising that authorised smoke-free products can present lower risks than cigarettes, regulators are acknowledging what tobacco harm reduction has long argued: combustion is the central danger. Adult smokers need clear, accurate information about alternatives that may help them move away from cigarettes. Public health policy should make safer choices easier to understand, not harder to access.
July 03, 2026 by reason.org
Southern California’s total tobacco bans aren’t helping public health
Southern California’s total tobacco bans raise serious questions about whether prohibition is improving public health or simply shifting behaviour elsewhere. When legal access is removed, consumers may turn to neighbouring markets, illicit sellers or more harmful products that remain easier to obtain. Policies aimed at reducing harm should be judged by real-world outcomes, not symbolic restrictions. Effective regulation should protect young people while preserving realistic pathways away from combustible tobacco.
July 02, 2026 by realclearscience.com
On Nicotine, FDA Embraces Science and Delivers a Public Health Victory
The FDA’s authorisation of modified risk claims for ZYN nicotine pouches marks a public health win for evidence-based risk communication. It recognises a simple but often ignored fact: smoke-free nicotine products do not carry the same risks as combustible cigarettes. For adult smokers, clear information about lower-risk alternatives can support better decisions and more realistic routes away from smoking. Public health should follow the science, not blur all nicotine products into the same category.
July 01, 2026 by reuters.com
FDA allows Philip Morris to market Zyn as less harmful than cigarettes
The FDA’s decision to allow ZYN nicotine pouches to be marketed as less harmful than cigarettes is a major moment for relative-risk communication. The agency has authorised claims for 20 ZYN products, recognising that switching completely from smoking to these smoke-free alternatives can reduce the risk of several serious diseases. For adult smokers, clear information matters: not all nicotine products carry the same level of harm. Public health should make evidence-based switching messages easier to understand, not harder to hear.